首页 | 本学科首页   官方微博 | 高级检索  
     

MRI在早期评价乳腺癌新辅助化疗效果中的应用
引用本文:杨英 综述,许卫,李坤成 审校. MRI在早期评价乳腺癌新辅助化疗效果中的应用[J]. 中国医学影像技术, 2011, 27(7): 1511-1514
作者姓名:杨英 综述  许卫  李坤成 审校
作者单位:首都医科大学宣武医院医学影像学部放射科,北京,100053
摘    要: 新辅助化疗(NAC)已成为局部进展期乳腺癌(LABC)的标准治疗方法。正确评价LABC对NAC的反应,对进一步选择适当的手术方式、判断患者预后意义重大。评价乳腺癌NAC疗效的影像学方法主要有超声、乳腺X线摄影和MRI。本文综述MRI在早期评价乳腺癌NAC疗效中的作用。

关 键 词:乳腺肿瘤  磁共振成像  新辅助化疗
收稿时间:2011-02-15
修稿时间:2011-03-29

MRI in predicting early changes of breast cancer during neoadjuvant chemotherapy
YANG Ying,XU Wei and LI Kun-cheng. MRI in predicting early changes of breast cancer during neoadjuvant chemotherapy[J]. Chinese Journal of Medical Imaging Technology, 2011, 27(7): 1511-1514
Authors:YANG Ying  XU Wei  LI Kun-cheng
Affiliation:Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
Abstract:Neoadjuvant chemotherapy (NAC) is the standard treatment for locally advanced breast cancer (LABC). Correct evaluation on the response of LABC to NAC plays an important role in further treatment and prognosis. The main medical imaging methods of evaluation on the efficacy of NAC include ultrasound, X-ray mammography and breast MRI. The early changes of breast cancer to NAC were reviewed in this article.
Keywords:Breast neoplasms  Magnetic resonance imaging  Neoadjuvant chemotherapy
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国医学影像技术》浏览原始摘要信息
点击此处可从《中国医学影像技术》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号